econazole has been researched along with Koch's Disease in 5 studies
Econazole: An imidazole derivative that is commonly used as a topical antifungal agent.
econazole : A racemate composed of equimolar amounts of (R)- and (S)-econazole. Used (as its nitrate salt) to treat skin infections such as athlete's foot, jock itch, ringworm and other fungal skin infections.
1-{2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl}imidazole : A member of the class of imidazoles that is 1-(2,4-dichlorophenyl)-2-(imidazol-1-yl)ethanol in which the hydroxyl hydrogen is replaced by a 4-chlorobenzyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The potential of econazole (ECZ) and moxifloxacin (MOX) individually against tuberculosis (TB) caused by multidrug-resistant and latent Mycobacterium tuberculosis has been demonstrated." | 7.74 | Novel chemotherapy for tuberculosis: chemotherapeutic potential of econazole- and moxifloxacin-loaded PLG nanoparticles. ( Ahmad, Z; Khuller, GK; Pandey, R; Sharma, S, 2008) |
| "The potential of econazole (ECZ) and moxifloxacin (MOX) individually against tuberculosis (TB) caused by multidrug-resistant and latent Mycobacterium tuberculosis has been demonstrated." | 3.74 | Novel chemotherapy for tuberculosis: chemotherapeutic potential of econazole- and moxifloxacin-loaded PLG nanoparticles. ( Ahmad, Z; Khuller, GK; Pandey, R; Sharma, S, 2008) |
| "The aim of the present study was to evaluate the chemotherapeutic potential of econazole against latent tuberculosis." | 3.73 | The potential of azole antifungals against latent/persistent tuberculosis. ( Ahmad, Z; Khuller, GK; Sharma, S, 2006) |
| "The present study was designed to evaluate the in vivo antimycobacterial potential of econazole alone and in combination with antitubercular drugs against tuberculosis in mice." | 3.73 | Azole antifungals as novel chemotherapeutic agents against murine tuberculosis. ( Ahmad, Z; Khuller, GK; Sharma, S, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kavanagh, ME | 1 |
| Coyne, AG | 1 |
| McLean, KJ | 1 |
| James, GG | 1 |
| Levy, CW | 1 |
| Marino, LB | 1 |
| de Carvalho, LP | 1 |
| Chan, DS | 1 |
| Hudson, SA | 1 |
| Surade, S | 1 |
| Leys, D | 1 |
| Munro, AW | 1 |
| Abell, C | 1 |
| Milano, A | 1 |
| Pasca, MR | 1 |
| Provvedi, R | 1 |
| Lucarelli, AP | 1 |
| Manina, G | 1 |
| Ribeiro, AL | 1 |
| Manganelli, R | 1 |
| Riccardi, G | 1 |
| Ahmad, Z | 3 |
| Sharma, S | 3 |
| Khuller, GK | 3 |
| Pandey, R | 1 |
5 other studies available for econazole and Koch's Disease
| Article | Year |
|---|---|
Fragment-Based Approaches to the Development of Mycobacterium tuberculosis CYP121 Inhibitors.
Topics: Bacterial Proteins; Binding Sites; Crystallography, X-Ray; Cytochrome P-450 Enzyme System; Drug Desi | 2016 |
Azole resistance in Mycobacterium tuberculosis is mediated by the MmpS5-MmpL5 efflux system.
Topics: Antifungal Agents; Azoles; Base Sequence; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cell Wall; Drug | 2009 |
The potential of azole antifungals against latent/persistent tuberculosis.
Topics: Animals; Antitubercular Agents; Clotrimazole; Colony Count, Microbial; Econazole; Lung; Mice; Mycoba | 2006 |
Azole antifungals as novel chemotherapeutic agents against murine tuberculosis.
Topics: Animals; Animals, Outbred Strains; Antibiotics, Antitubercular; Antifungal Agents; Antitubercular Ag | 2006 |
Novel chemotherapy for tuberculosis: chemotherapeutic potential of econazole- and moxifloxacin-loaded PLG nanoparticles.
Topics: Administration, Oral; Animals; Antitubercular Agents; Aza Compounds; Drug Carriers; Drug Compounding | 2008 |